The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Chan, Conrad E ^a,e   Götze, Sebastian ^b,c   Seah, Geok T ^a   Seeberger, Peter H ^b,c   Tukvadze, Nestan ^d   Wenk, Markus R ^a   Hanson, Brendon J ^e   MacAry, Paul A ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d National Center for Tuberculosis and Lung Diseases   (Georgia)

^e DSO NATIONAL LABORATORIES   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; LIPOARABINOMANNAN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; PEPTIDE LIBRARY; VIRULENCE FACTOR;

BLOOD; HUMAN; IMMUNOLOGY; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; PEPTIDE LIBRARY; TUBERCULOSIS, PULMONARY; URINE;

ANTIBODIES; BIOMARKERS; HUMANS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE LIBRARY; TUBERCULOSIS, PULMONARY; VIRULENCE FACTORS;

EID: 84929379658     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10281     Document Type: Article

References (31)

1. Global Tuberculosis Report 2013. (World Health Organization, 2013).
2. Keeler, E. et al. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444 Suppl 1, 49-57 (2006).
3. Kambashi, B. et al. Utility of nucleic acid amplification techniques for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int. J Tuberc Lung Dis. 5, 364-369 (2001).
4. Steingart, K. R. et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect. Dis. 6, 664-674 (2006).
5. Elliott, A. M. et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis. 74, 191-194 (1993).
6. Boehme, C. et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans. R Soc. Trop. Med. Hyg. 99, 893-900, (2005).
7. Dheda, K. et al. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 5, e9848 (2010).
8. Sada, E., Aguilar, D., Torres, M. & Herrera, T. Detection of lipoarabinomannan as a diagnostic test for tuberculosis. J Clin Microbiol. 30, 2415-2418 (1992).
9. Minion, J. et al. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur. Respir. J 38, 1398-1405 (2011).
10. Nigou, J., Gilleron, M. & Puzo, G. Lipoarabinomannans: from structure to biosynthesis. Biochimie 85, 153-166 (2003).
11. Reither, K. et al. Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis. BMC Infect. Dis. 9, 141 (2009).
12. Savolainen, L. et al. Modification of clearview tuberculosis (TB) enzyme-linked immunosorbent assay for TB patients not infected with HIV. Clin Vaccine Immunol. 20, 1479-1482 (2013).
13. Talbot, E. et al. Test characteristics of urinary lipoarabinomannan and predictors of mortality among hospitalized HIV-infected tuberculosis suspects in Tanzania. PLoS One 7, e32876 (2012).
14. Horlacher, T. & Seeberger, P. H. Carbohydrate arrays as tools for research and diagnostics. Chem. Soc. Rev. 37, 1414-1422 (2008).
15. McCloskey, N., Turner, M. W., Steffner, P., Owens, R. & Goldblatt, D. Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses. Immunology 88, 169-173 (1996).
16. Orholm, M., Holten-Andersen, W. & Lundgren, J. D. Improved detection of Pneumocystis carinii by an immunofluorescence technique using monoclonal antibodies. Eur. J Clin Microbiol. Infect. Dis. 9, 880-885 (1990).
17. Wood, R. et al. Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria. BMC Infect. Dis. 12, 47 (2012).
18. Sarkar, S. et al. A bispecific antibody based assay shows potential for detecting tuberculosis in resource constrained laboratory settings. PLoS One 7, e32340 (2012).
19. Schoonbroodt, S. et al. Engineering antibody heavy chain CDR3 to create a phage display Fab library rich in antibodies that bind charged carbohydrates. J Immunol. 181, 6213-6221 (2008).
20. Mao, S. et al. Phage-display library selection of high-affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewisx and Lewisx. Proc. Natl. Acad. Sci. USA 96, 6953-6958 (1999).
21. Kaur, D., Lowary, T. L., Vissa, V. D., Crick, D. C. & Brennan, P. J. Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans. Microbiology 148, 3049-3057 (2002).
22. Shinnick, T. M. & Good, R. C. Mycobacterial taxonomy. Eur. J Clin Microbiol. Infect Dis. 13, 884-901 (1994).
23. Griffith, D. E. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir. Crit. Care Med. 175, 367-416 (2007).
24. Gibson, K. J. et al. Tsukamurella paurometabola lipoglycan, a new lipoarabinomannan variant with pro-inflammatory activity. J Biol. Chem. 279, 22973-22982 (2004).
25. McGrath, E. E., J. McCabe, and P. B. Anderson, Guidelines on the diagnosis and treatment of pulmonary non-tuberculous mycobacteria infection. Int. J Clin Pract., 62, 1947-55. (2008).
26. Flores, L. L. et al. Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis. Clin Vaccine Immunol. 18, 1616-1627 (2011).
27. Guidelines on the management of latent tuberculosis infection. (World Health Organization, 2015).
28. Theron, G. et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir. Crit. Care Med. 184, 132-140 (2011).
29. Schmidt, R. et al. Single-molecule detection on a protein-array assay platform for the exposure of a tuberculosis antigen. J Proteome. Res. 10, 1316-1322, (2011).
30. de Haard, H. J. et al. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol. Chem. 274, 18218-18230 (1999).
31. Lim, A. P. et al. Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library. Virol. J 5, 130, (2008).